News

Sanofi (and its subsidiary Genzyme) announced yesterday that it has received a Complete Response Letter from the FDA for Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis. Lemtrada was... READ MORE

As discussed in Laura’s latest blog Lemtrada – Sanofi’s Request for a new MS Drug, the Food and Drug Administration is expected to make a decision regarding the approval of Lemtrada (alemtuzumab)... READ MORE

The FDA is considering the approval of Lemtrada (alemtuzumab), a redesigned version of Sanofi’s drug CAMPATH, which has been used for over 10 years in treating a certain form of Leukemia. The... READ MORE

“Improving Lives Today”. That is the tag line of the Multiple Sclerosis Association of America, or MSAA. Helping people with MS is our primary goal at MultipleSclerosis.Net, and seeing that tagline made... READ MORE

A recent article appearing in Healthcare Professionals Network1 reported a study where the white matter of the brain is not where answers for Multiple Sclerosis will be found. It found that gray... READ MORE

Several studies regarding incidence and prevalence rates of multiple sclerosis in various areas of the world have been released in recent weeks. Earlier this week was the announcement of the 2013 Atlas... READ MORE

Multiple Sclerosis patients are again seeing headlines about a disease modifying drug causing Progressive Multifocal Leukoencephalopathy, or PML, in a patient – this time that drug is Gilenya (fingolimod), the oral pill... READ MORE

Multiple sclerosis is an autoimmune disease in which the immune system goes rogue and attacks and destroys myelin, the fatty, protective layer of tissue which insulates nerves and helps to transmit electrical... READ MORE

Before the Internet, having Multiple Sclerosis meant launching your own private awareness campaign to educate others about MS. Why are you always tired? Why do you walk like you’re drunk? Why can’t... READ MORE

Today Biogen Idec announced in its press release the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY™ (peginterferon beta-1a) for the... READ MORE

Only weeks following the exciting news that Tecfidera (oral dimethyl fumarate), also known as BG-12, has been approved by the FDA for the treatment of relapsing forms of multiple sclerosis, the headlines... READ MORE

Beyond slowing down the disease through the use of disease-modifying therapies, researchers are looking to repair damage to the central nervous system caused by MS. Myelin repair is a promising area of... READ MORE